CN102441156A - Traditional Tibetan medicinal composition and preparation method thereof - Google Patents
Traditional Tibetan medicinal composition and preparation method thereof Download PDFInfo
- Publication number
- CN102441156A CN102441156A CN2011104207638A CN201110420763A CN102441156A CN 102441156 A CN102441156 A CN 102441156A CN 2011104207638 A CN2011104207638 A CN 2011104207638A CN 201110420763 A CN201110420763 A CN 201110420763A CN 102441156 A CN102441156 A CN 102441156A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- tibetan medicine
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a traditional Tibetan medicinal composition and a preparation method thereof. The traditional Tibetan medicinal composition is prepared from the following raw materials in part by weight: 200 to 300 parts of myrobalan, 200 to 300 parts of corydalis pygmaea, 200 to 300 parts of fructus terminaliae billericae, 100 to 150 parts of Tibetan lithospermum, 350 to 450 parts of phyllanthus emblica, 250 to 350 parts of caragana jubata, 150 to 250 parts of sea-buckthorn, 100 to 150 parts of madder, 200 to 300 parts of Baxiaga, 330 to 430 parts of dalbergia wood, 200 to 300 parts of dry ginger, 200 to 300 parts of Lagotisglauca, 100 to 150 parts of catechu, 80 to 120 parts of rhodiola rosea, 100 to 150 parts of dracocephalum tanguticum, 200 to 300 parts of berberidaceae bark and 150 to 250 parts of rheum officinale. In a medicament of the traditional Tibetan medicinal composition, purely natural traditional Tibetan medicinal materials serve as raw materials, and the base is the theory of 'Rgyud-bzhi' of Tibetan medicine. While treating plethora, hyperlipidemia and high blood pressure, the traditional Tibetan medicinal composition can inhibit pathological changes of important organs, such as heart, brain, liver, kidney and the like to the large extent and can regulate constitution.
Description
Technical field
The present invention relates to a kind of treatment plethora, hyperlipidemia, hypertension, and the cerebral thrombosis that causes, cardiopalmus are irritated, dizzy, the medicine of cervical vertebra ache disease, specifically, be a kind of be the Tibetan medicine compositions and the method for preparing of raw material with the Tibetan medicine material.
Background technology
Plethora is the disease performance of erythrocytosis, is called erythrocytosis again.This type is sick to divide two kinds: a kind of is caused by erythrocyte itself, is called polycythemia vera; A kind of is after having suffered from certain disease, to show as plethoric symptom, is called symptomatic erythrocytosis.Polycythemia vera, it is comparatively common in plateau crowd more than 3000 meters to be more common in later people, especially height above sea level of middle age, has the patient of nearly half to suffer from hypertension and spleen enlargement respectively approximately.Its course of disease slower development has 10 years, 20 years even longer.Can inspire cardiovascular obstacle or severe haemorrhage between this stadium and accompanying infection, leukemia etc., the caused death that has suffering from.
Hyperlipidemia is that lipid metabolism or running make one or more lipids of blood plasma be higher than normal situation unusually.Hyperlipidemia is a kind of systemic disease, and blood cholesterol (TC) and/or triglyceride (TG) are too high or HDL-C (HDL-C) is low excessively, and modern medicine is called dyslipidemia.Hyperlipidemia is the risk factor of coronary heart disease, myocardial infarction, sudden death.In addition, hyperlipidemia also is to impel an important risk factor of hypertension, impaired glucose tolerance, diabetes.Hyperlipidemia also can cause fatty liver, liver cirrhosis, cholelithiasis, pancreatitis, retinal hemorrhage, blind, peripheral vascular disease, limping, hyperuricemia etc.
Hypertension is a kind of polygenic inheritance, and closely related with environment and people's factors such as emotion, thus cause with the hypertension be the performance general disease; Make human nerve movable unusual, cause motion of cerebral cortex and veins beneath the skin and neuroregulation obstacle, the arteriotony that causes the vasospasm of whole body small artery to produce increases and causes kidney vasospasm; And cause renal ischaemia, and the characteristic that a series of body fluid that cause change, human endocrine is participated in this complicated course of reaction; Cause the whole body endocrine to reduce or loss, thereby facilitate the whole body arteriolosclerosis gradually, these diseased regions send pathologic to cerebral cortex again and impact; Impel function of cortex disorderly; Form vicious cycle, finally cause the formation of " hypertension ", and by light to weight.Human body particularly middle-aged and elderly people along with constantly aging in the objective natural environment; The whole body blood vessel is constantly sclerosis thereupon also; Cause the atrophy of brain and the generation of cerebrovascular, this mostly is because the hepatic and renal YIN deficiency or yang deficiency make cerebral ischemia; Thereby apoplexy occurs, generally speaking hypertension is that a kind of the rising with body fluid circulation, arteriotony is master's syndrome.
The medical history of plethora, hyperlipidemia, hyperpietic's ubiquity several years, more than ten years even decades is fundamentally executed the medicine of controlling owing to lack at present, cause needs of patients to be taken medicine for a long time, and curative effect is not satisfactory.
Summary of the invention
To the problem that prior art exists, main purpose of the present invention is to provide a kind of treatment plethora, hyperlipidemia, hypertensive Tibetan medicine composition and method of making the same.
For realizing above-mentioned purpose, the present invention provides a kind of embodiment of Tibetan medicine compositions, and this Tibetan medicine compositions is the medicament of being processed by the following weight proportion raw material:
200~300 parts of Fructus Chebulaes, 200~300 parts of Herba Corydalis, 200~300 parts of Fructus Terminaliae Billericaees, 100~150 parts of Radix onosmatiss, 350~450 parts of Fructus Phyllanthis, 250~350 parts of caraganas, 150~250 parts of Fructus Hippophaes, 100~150 parts in Radix Rubiae, 200~300 parts of BAXIAGAs, 330~430 parts of Lignum Dalbergiae Odoriferaes, 200~300 parts of Rhizoma Zingiberiss, 200~300 parts of Radix Pecteilis susannae, 100~150 parts in catechu, 80~120 parts of Radix Rhodiolaes, 100~150 parts of tangut dragonheads, 200~300 parts of Radix Berberidis Amurensis, 150~250 parts of Radix Et Rhizoma Rhei.
Further, this Tibetan medicine compositions is the medicament of being processed by the following weight proportion raw material:
240 parts of Fructus Chebulaes, 240 parts of Herba Corydalis, 240 parts of Fructus Terminaliae Billericaees, 120 parts of Radix onosmatiss, 400 parts of Fructus Phyllanthis, 300 parts of caraganas, 180 parts of Fructus Hippophaes, 120 parts in Radix Rubiae, 240 parts of BAXIAGAs, 360 parts of Lignum Dalbergiae Odoriferaes, 240 parts of Rhizoma Zingiberiss, 240 parts of Radix Pecteilis susannae, 120 parts in catechu, 100 parts of Radix Rhodiolaes, 120 parts of tangut dragonheads, 240 parts of Radix Berberidis Amurensis, 180 parts of Radix Et Rhizoma Rhei.
Further, the medicament of this Tibetan medicine compositions can be capsule, tablet or pill.
The medicament of this Tibetan medicine compositions can be used for treating plethora or hyperlipidemia or hypertension or the cerebral thrombosis that is caused by plethora, hyperlipidemia, hypertension, irritated, dizzy, the cervical vertebra ache of cardiopalmus.
The present invention also provides a kind of embodiment of Tibetan medicine preparation of compositions method, and it is to be prepared by the following step:
(1) by following weight proportion weighting raw materials: 200~300 parts of Fructus Chebulaes; 200~300 parts of Herba Corydalis; 200~300 parts of Fructus Terminaliae Billericaees; 100~150 parts of Radix onosmatiss; 350~450 parts of Fructus Phyllanthis; 250~350 parts of caraganas; 150~250 parts of Fructus Hippophaes; 100~150 parts in Radix Rubiae; 200~300 parts of BAXIAGAs; 330~430 parts of Lignum Dalbergiae Odoriferaes; 200~300 parts of Rhizoma Zingiberiss; 200~300 parts of Radix Pecteilis susannae; 100~150 parts in catechu; 80~120 parts of Radix Rhodiolaes; 100~150 parts of tangut dragonheads; 200~300 parts of Radix Berberidis Amurensis; 150~250 parts of Radix Et Rhizoma Rhei;
(2) crude drug is cleaned, dries, breaks into powder;
(3) sieve with mesh sieve;
(4) powder after will sieving is admixed mixing.
Further, the embodiment of this Tibetan medicine preparation of compositions method also comprises the steps: the powder filled capsules.
Further, the mesh sieve in this step (3) is 120 mesh sieves.
The present invention is with respect to prior art, and (1) has the effect of treating both the principal and secondary aspects of a disease.It is raw material that the medicament of this Tibetan medicine compositions adopts the Tibetan medicine material of pure natural; Be the basis with Tibetan medicine's Four-Volume Medical Code theory; In treatment plethora, hyperlipidemia, hypertensive while, can suppress the pathological changes of important internal organs such as the heart, brain, liver, kidney to greatest extent, carry out the integral body adjustment; (2) can remove blowdown, blood fat reducing and blood viscosity are removed the poisonous and garbage substance in the blood rapidly, reduce vascular resistance, recover blood vessel elasticity, alleviate cardiac pressure, comprise the headache, dizziness, insomnia, the cardio palmus that cause thus; (3) adopt multiple comprehensive drug treatment, suppress erythrocytosis, improve the blood supply circulation, the blood pressure of regulation and control imbalance is corrected the three categories of etiologic factors balance, removes the balance muscular spasm, makes blood pressure normalization; (4) nourishing liver and kidney, what break traditions is the blood pressure lowering blood pressure lowering, through adjusting the imbalance of each internal organs, Tibetan medicine's three big genic unbalances the excess in the upper and deficiency in the lower and the wind-fire expectorant stasis of blood extremely; (5) steadily blood pressure lowering, when medicine was obeyed to a certain degree, medicine is slow release slowly, and the human body self muscle regulation and control blood pressure mechanism normalization that brings into operation is up to basic rehabilitation and lasting stability; (6) can thoroughly effect a radical cure diseases such as plethora, hyperlipidemia, hypertension, not need to take medicine for a long time, after the bioactive molecule in the medicine gets into human body, can activate and regulate disorderly hormonal system, make it be tending towards normal secretion.
The specific embodiment
Embodiment 1
Tibetan medicine compositions of the present invention is the medicament of being processed by the following weight proportion raw material:
Fructus Chebulae 240g, Herba Corydalis 240g, Fructus Terminaliae Billericae 240g, Radix onosmatis 120g, Fructus Phyllanthi 400g, caragana 300g, Fructus Hippophae 180g, Radix Rubiae 120g, BAXIAGA 240g, Lignum Dalbergiae Odoriferae 360g, Rhizoma Zingiberis 240g, Radix Pecteilis susannae 240g, catechu 120g, Radix Rhodiolae 100g, tangut dragonhead 120g, Radix Berberidis Amurensis 240g, Radix Et Rhizoma Rhei 180g.
The medicament of this Tibetan medicine compositions is a capsule, and this medicament can be used for treating plethora or hyperlipidemia or hypertension or the cerebral thrombosis that is caused by plethora, hyperlipidemia, hypertension, irritated, dizzy, the cervical vertebra ache of cardiopalmus.
Tibetan medicine preparation of compositions method of the present invention comprises the steps:
(1) by following weight proportion weighting raw materials: Fructus Chebulae 240g, Herba Corydalis 240g, Fructus Terminaliae Billericae 240g, Radix onosmatis 120g, Fructus Phyllanthi 400g, caragana 300g, Fructus Hippophae 180g, Radix Rubiae 120g, BAXIAGA 240g, Lignum Dalbergiae Odoriferae 360g, Rhizoma Zingiberis 240g, Radix Pecteilis susannae 240g, catechu 120g, Radix Rhodiolae 100g, tangut dragonhead 120g, Radix Berberidis Amurensis 240g, Radix Et Rhizoma Rhei 180g;
(2) crude drug is cleaned, dries, with disintegrating machine it broken into powder;
(3) sieve with 120 mesh sieves;
(4) powder after will sieving is admixed mixing;
(5) with the powder filled capsules.
Embodiment 2
Tibetan medicine compositions of the present invention is the medicament of being processed by the following weight proportion raw material:
Fructus Chebulae 300g, Herba Corydalis 300g, Fructus Terminaliae Billericae 300g, Radix onosmatis 150g, Fructus Phyllanthi 450g, caragana 350g, Fructus Hippophae 250g, Radix Rubiae 150g, BAXIAGA 300g, Lignum Dalbergiae Odoriferae 430g, Rhizoma Zingiberis 300g, Radix Pecteilis susannae 300g, catechu 150g, Radix Rhodiolae 120g, tangut dragonhead 150g, Radix Berberidis Amurensis 300g, Radix Et Rhizoma Rhei 250g.
The medicament of this Tibetan medicine compositions is a tablet, and this medicament can be used for treating plethora or hyperlipidemia or hypertension or the cerebral thrombosis that is caused by plethora, hyperlipidemia, hypertension, irritated, dizzy, the cervical vertebra ache of cardiopalmus.
Tibetan medicine preparation of compositions method of the present invention comprises the steps:
(1) by following weight proportion weighting raw materials: Fructus Chebulae 300g, Herba Corydalis 300g, Fructus Terminaliae Billericae 300g, Radix onosmatis 150g, Fructus Phyllanthi 450g, caragana 350g, Fructus Hippophae 250g, Radix Rubiae 150g, BAXIAGA 300g, Lignum Dalbergiae Odoriferae 430g, Rhizoma Zingiberis 300g, Radix Pecteilis susannae 300g, catechu 150g, Radix Rhodiolae 120g, tangut dragonhead 150g, Radix Berberidis Amurensis 300g, Radix Et Rhizoma Rhei 250g;
(2) crude drug is cleaned, dries, with disintegrating machine it broken into powder;
(3) sieve with 120 mesh sieves;
(4) powder after will sieving is admixed mixing;
(5) pressed powder is processed tablet.
Embodiment 3
Tibetan medicine compositions of the present invention is the medicament of being processed by the following weight proportion raw material:
Fructus Chebulae 200g, Herba Corydalis 200g, Fructus Terminaliae Billericae 200g, Radix onosmatis 100g, Fructus Phyllanthi 350g, caragana 250g, Fructus Hippophae 150g, Radix Rubiae 100g, BAXIAGA 200g, Lignum Dalbergiae Odoriferae 330g, Rhizoma Zingiberis 200g, Radix Pecteilis susannae 200g, catechu 100g, Radix Rhodiolae 80g, tangut dragonhead 100g, Radix Berberidis Amurensis 200g, Radix Et Rhizoma Rhei 150g.
The medicament of this Tibetan medicine compositions is a pill, and this medicament can be used for treating plethora or hyperlipidemia or hypertension or the cerebral thrombosis that is caused by plethora, hyperlipidemia, hypertension, irritated, dizzy, the cervical vertebra ache of cardiopalmus.
Tibetan medicine preparation of compositions method of the present invention comprises the steps:
(1) by following weight proportion weighting raw materials: Fructus Chebulae 200g, Herba Corydalis 200g, Fructus Terminaliae Billericae 200g, Radix onosmatis 100g, Fructus Phyllanthi 350g, caragana 250g, Fructus Hippophae 150g, Radix Rubiae 100g, BAXIAGA 200g, Lignum Dalbergiae Odoriferae 330g, Rhizoma Zingiberis 200g, Radix Pecteilis susannae 200g, catechu 100g, Radix Rhodiolae 80g, tangut dragonhead 100g, Radix Berberidis Amurensis 200g, Radix Et Rhizoma Rhei 150g;
(2) crude drug is cleaned, dries, with disintegrating machine it broken into powder;
(3) sieve with 120 mesh sieves;
(4) powder after will sieving is admixed mixing;
(5) powder is processed pill.
Can above-mentioned capsule, tablet or pill be packed with the plastic-aluminum bubble-cap at last.
More than introduced a kind of treatment plethora, hyperlipidemia, hypertension, and the cerebral thrombosis that causes, cardiopalmus are irritated, dizzy, the Tibetan medicine composition and method of making the same of cervical vertebra ache disease.The present invention is not limited to above embodiment, does not anyly break away from technical scheme of the present invention, promptly only it is carried out improvement or the change that those of ordinary skills knew, all belongs within protection scope of the present invention.
Claims (7)
1. a Tibetan medicine compositions is characterized in that, it is the medicament of being processed by the following weight proportion raw material:
200~300 parts of Fructus Chebulaes, 200~300 parts of Herba Corydalis, 200~300 parts of Fructus Terminaliae Billericaees, 100~150 parts of Radix onosmatiss, 350~450 parts of Fructus Phyllanthis, 250~350 parts of caraganas, 150~250 parts of Fructus Hippophaes, 100~150 parts in Radix Rubiae, 200~300 parts of BAXIAGAs, 330~430 parts of Lignum Dalbergiae Odoriferaes, 200~300 parts of Rhizoma Zingiberiss, 200~300 parts of Radix Pecteilis susannae, 100~150 parts in catechu, 80~120 parts of Radix Rhodiolaes, 100~150 parts of tangut dragonheads, 200~300 parts of Radix Berberidis Amurensis, 150~250 parts of Radix Et Rhizoma Rhei.
2. Tibetan medicine compositions according to claim 1 is characterized in that, it is the medicament of being processed by the following weight proportion raw material:
240 parts of Fructus Chebulaes, 240 parts of Herba Corydalis, 240 parts of Fructus Terminaliae Billericaees, 120 parts of Radix onosmatiss, 400 parts of Fructus Phyllanthis, 300 parts of caraganas, 180 parts of Fructus Hippophaes, 120 parts in Radix Rubiae, 240 parts of BAXIAGAs, 360 parts of Lignum Dalbergiae Odoriferaes, 240 parts of Rhizoma Zingiberiss, 240 parts of Radix Pecteilis susannae, 120 parts in catechu, 100 parts of Radix Rhodiolaes, 120 parts of tangut dragonheads, 240 parts of Radix Berberidis Amurensis, 180 parts of Radix Et Rhizoma Rhei.
3. according to claim 1 or 2 arbitrary described Tibetan medicine compositionss, it is characterized in that described medicament is capsule or tablet or pill.
4. Tibetan medicine compositions according to claim 3 is characterized in that, said medicament can be used for treating plethora or hyperlipidemia or hypertension or the cerebral thrombosis that is caused by plethora, hyperlipidemia, hypertension, irritated, dizzy, the cervical vertebra ache of cardiopalmus.
5. Tibetan medicine preparation of compositions method according to claim 1 is characterized in that, it is to be prepared by the following step:
(1) by following weight proportion weighting raw materials: 200~300 parts of Fructus Chebulaes; 200~300 parts of Herba Corydalis; 200~300 parts of Fructus Terminaliae Billericaees; 100~150 parts of Radix onosmatiss; 350~450 parts of Fructus Phyllanthis; 250~350 parts of caraganas; 150~250 parts of Fructus Hippophaes; 100~150 parts in Radix Rubiae; 200~300 parts of BAXIAGAs; 330~430 parts of Lignum Dalbergiae Odoriferaes; 200~300 parts of Rhizoma Zingiberiss; 200~300 parts of Radix Pecteilis susannae; 100~150 parts in catechu; 80~120 parts of Radix Rhodiolaes; 100~150 parts of tangut dragonheads; 200~300 parts of Radix Berberidis Amurensis; 150~250 parts of Radix Et Rhizoma Rhei;
(2) crude drug is cleaned, dries, breaks into powder;
(3) sieve with mesh sieve;
(4) powder after will sieving is admixed mixing.
6. Tibetan medicine preparation of compositions method according to claim 5 is characterized in that, also comprises the steps: the powder filled capsules.
7. Tibetan medicine preparation of compositions method according to claim 5 is characterized in that the mesh sieve in the said step (3) is 120 mesh sieves.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110420763 CN102441156B (en) | 2011-12-14 | 2011-12-14 | Traditional Tibetan medicinal composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110420763 CN102441156B (en) | 2011-12-14 | 2011-12-14 | Traditional Tibetan medicinal composition and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102441156A true CN102441156A (en) | 2012-05-09 |
CN102441156B CN102441156B (en) | 2013-06-12 |
Family
ID=46004416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110420763 Active CN102441156B (en) | 2011-12-14 | 2011-12-14 | Traditional Tibetan medicinal composition and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102441156B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102716347A (en) * | 2012-06-29 | 2012-10-10 | 宋永心 | Tibetan medicine for treating hypertension and preparation method thereof |
CN103330858A (en) * | 2013-07-10 | 2013-10-02 | 宋永心 | Tibetan medicine used for treating cerebral thrombus and preparation method thereof |
CN105250353A (en) * | 2015-10-16 | 2016-01-20 | 白玛仁增 | Compound Tibetan medicine for treating polycythemia |
CN106728882A (en) * | 2015-11-19 | 2017-05-31 | 哈尔滨圣吉药业股份有限公司 | A kind of Lagotis glauca warming kidney and enhancing body electuary and preparation method thereof |
CN111000011A (en) * | 2019-12-24 | 2020-04-14 | 同德县尕藏农牧产品销售有限责任公司 | Tangut dragonhead tea and preparation method thereof |
CN114984141A (en) * | 2022-07-01 | 2022-09-02 | 西藏藏医药大学附属医院 | Tibetan medicine composition for promoting blood circulation to remove blood stasis and promoting blood circulation to regulate qi, and preparation method and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709447A (en) * | 2005-07-06 | 2005-12-21 | 甘肃奇正藏药有限公司 | Tibetan medicine formulation for treating hyperlipemia, and its preparing method |
CN1709448A (en) * | 2005-07-06 | 2005-12-21 | 甘肃奇正藏药有限公司 | Tibetan medicine for treating women's diseases, and its preparing method |
CN1813979A (en) * | 2005-11-29 | 2006-08-09 | 久美彭措 | Collateral-flow-activating capsule |
CN102058817A (en) * | 2010-11-01 | 2011-05-18 | 西藏金哈达药业有限公司 | Tibetan medicinal preparation for treating liver diseases |
CN102068653A (en) * | 2010-11-01 | 2011-05-25 | 西藏金哈达药业有限公司 | Medicament for preparing Tibetan medicament preparation for treating liver diseases |
-
2011
- 2011-12-14 CN CN 201110420763 patent/CN102441156B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709447A (en) * | 2005-07-06 | 2005-12-21 | 甘肃奇正藏药有限公司 | Tibetan medicine formulation for treating hyperlipemia, and its preparing method |
CN1709448A (en) * | 2005-07-06 | 2005-12-21 | 甘肃奇正藏药有限公司 | Tibetan medicine for treating women's diseases, and its preparing method |
CN1813979A (en) * | 2005-11-29 | 2006-08-09 | 久美彭措 | Collateral-flow-activating capsule |
CN102058817A (en) * | 2010-11-01 | 2011-05-18 | 西藏金哈达药业有限公司 | Tibetan medicinal preparation for treating liver diseases |
CN102068653A (en) * | 2010-11-01 | 2011-05-25 | 西藏金哈达药业有限公司 | Medicament for preparing Tibetan medicament preparation for treating liver diseases |
Non-Patent Citations (2)
Title |
---|
徐树楠等: "高血压病从络论治探析", 《中医杂志》 * |
蔡乐等: "藏药二十八味槟榔丸的鉴别及没食子酸的含量测定", 《华西药学杂志》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102716347A (en) * | 2012-06-29 | 2012-10-10 | 宋永心 | Tibetan medicine for treating hypertension and preparation method thereof |
CN103330858A (en) * | 2013-07-10 | 2013-10-02 | 宋永心 | Tibetan medicine used for treating cerebral thrombus and preparation method thereof |
CN103330858B (en) * | 2013-07-10 | 2014-07-30 | 宋永心 | Tibetan medicine used for treating cerebral thrombus and preparation method thereof |
CN105250353A (en) * | 2015-10-16 | 2016-01-20 | 白玛仁增 | Compound Tibetan medicine for treating polycythemia |
CN106728882A (en) * | 2015-11-19 | 2017-05-31 | 哈尔滨圣吉药业股份有限公司 | A kind of Lagotis glauca warming kidney and enhancing body electuary and preparation method thereof |
CN111000011A (en) * | 2019-12-24 | 2020-04-14 | 同德县尕藏农牧产品销售有限责任公司 | Tangut dragonhead tea and preparation method thereof |
CN114984141A (en) * | 2022-07-01 | 2022-09-02 | 西藏藏医药大学附属医院 | Tibetan medicine composition for promoting blood circulation to remove blood stasis and promoting blood circulation to regulate qi, and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102441156B (en) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102441156B (en) | Traditional Tibetan medicinal composition and preparation method thereof | |
CN101612362B (en) | Complex preparation for regulating lipid and preventing and curing heart cerebrovascular diseases and preparation method thereof | |
CN103181552A (en) | Health care food for regulating blood lipid and preparation method thereof | |
CN104689105A (en) | Medicine and food homologous plant product and preparation method thereof | |
CN105287614B (en) | A kind of Dengyin naotong pharmaceutical composition and preparation method thereof, preparation and application | |
CN109432181A (en) | Alleviate the composition and the preparation method and application thereof of depression | |
CN103169765A (en) | Eucommia ulmoides seed oil and red rice compound soft capsule preparation and preparation method thereof | |
CN103005448B (en) | Health-care food composition for improving anoxia endurance and preparation method thereof | |
CN101766666A (en) | Chinese medicament for treating cardiovascular and cerebrovascular diseases | |
CN101249207A (en) | Medicament prescription for treating coronary heart disease | |
CN103027944A (en) | Pharmaceutical composition for preventing and treating cardiovascular and cerebrovascular disease | |
CN103525640B (en) | Energy-keeping yang-tonifying wine | |
CN106729518A (en) | A kind of tea beverage of hypotensive and preparation method and application | |
CN109620863A (en) | A kind of composition and the preparation method and application thereof for alleviating depression | |
CN102205010A (en) | Pharmaceutical composition with auxiliary function of reducing blood fat | |
CN106109951A (en) | Prevent and treat medicine of hyperglycemia, hyperlipidemia, hypertension and preparation method thereof | |
CN1718191A (en) | Total secondary ginseng glucoside oral disintegration tablets prepn. method and application thereof | |
CN103656012B (en) | A kind of preparation method treating treating coronary heart disease and angina pectoris compositions | |
CN106474190A (en) | A kind of medicine for treating type Ⅱdiabetes mellitus and complication and preparation method thereof | |
CN108096536A (en) | A kind of Chinese medicine composition for treating hemiplegia | |
CN103961603B (en) | Traditional Chinese medicine preparationcapable of reducing blood fat and freeing vessels | |
CN107296817B (en) | Use of Poria extract and temmoic acid for protecting muscle | |
CN107582866A (en) | Dendrobium candidum and Amlodipine are preparing the application process in treating hypertension drug | |
CN100409868C (en) | Chinese medicine for cardiac and encephalic ischemia | |
CN102327566B (en) | Traditional Chinese medicine preparation for curing ventricular extrasystole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |